Lower rates of consistent urine drug tests for prescribed psychotropic medications among patients on opioid replacement therapy.
Patients on opioid replacement therapy (ORT) to treat opioid use disorder are frequently monitored for these medications, but it is not known if they are also adhering to their psychotropic medications. This is an analysis of measure of potential adherence to psychotropic medications by patients on ORT.



This is a retrospective cohort study of patients (n=1470) on antidepressants and/or antipsychotics and tested by the Millennium Health laboratory. Potential adherence to psychotropic medications was measured by urine drug test (UDT) results. The consistency of UDT for expected psychotropic medication in patients on ORT was compared to patients not on ORT (control group) during 3-months period. The study used propensity score methods to match individuals from both groups on their demographics and their psychotropic medication.



There were 457 participants (31.09%) on ORT and 1013 participants (68.91%) in the control group. Only 55.33% of UDTs (n=1388) were consistent for expected psychotropic medications in the ORT group compared to 73.69% of UDTs (n=4953) consistent for expected psychotropic medications in the control group (χ2=172.99, p<0.001). After matching, patients in the ORT group were less likely than the control group to have consistent UDTs for expected psychotropic medications (OR: 0.81, 95% CI: 0.76-0.85, P<0.001).



There is a high rate of inconsistent UDT for prescribed psychotropic medication among patients on ORT. This could reflect potential poor adherence. Monitoring adherence to psychotropic medications should be part of every clinical visit for patients on ORT.
Dept of Psychiatry, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dept of Psychiatry, University of Toronto, Canada. Electronic address: ahmed.hassan@camh.ca.
Ahmed N
AN
Hassan
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use* / Q000652:urine; D014150:Antipsychotic Agents / Q000627:therapeutic use* / Q000652:urine; D003866:Depressive Disorder / Q000188:drug therapy / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use* / Q000652:urine; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000652:urine; D011618:Psychotic Disorders / Q000188:drug therapy / Q000652:urine; D012189:Retrospective Studies; D055815:Young Adult
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D009294:Narcotics
Adherence; Dual diagnosis; Opioid replacement therapy; Psychotropic medications; Urine drug test